DocCheck (AJ91.DE) Stock Price

DocCheck Price

XETRA·CLOSED
11.50EUR-0.30 (-2.58 %)
Market closed

Revenue has compounded at 7.7% per year over the past 19 years to 55.32 M EUR. Earnings per share have grown at 10.3% per year over the last 19 years. DocCheck's net margin stands at 9.6%, down from 13.3% several years earlier. DocCheck currently offers a dividend yield of about 6.52%. The payout ratio is around 71% of earnings. The dividend has grown at 8.8% per year over the past 13 years. The stock trades about 6% above its 52-week low.

DocCheck stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of DocCheck over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how DocCheck stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing DocCheck's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

DocCheck Stock Price History
DateDocCheck Price
7/23/202611.50 EUR
7/22/202611.80 EUR
7/21/202611.80 EUR
7/20/202611.80 EUR
7/17/202611.90 EUR
7/16/202611.90 EUR
7/15/202612.10 EUR
7/14/202612.10 EUR
7/13/202612.10 EUR
7/10/202612.00 EUR
7/9/202611.90 EUR
7/8/202611.90 EUR
7/7/202611.90 EUR
7/6/202611.80 EUR
7/3/202611.70 EUR
7/2/202611.60 EUR
7/1/202611.50 EUR
6/30/202611.50 EUR
6/29/202611.50 EUR
6/26/202611.50 EUR
6/25/202611.70 EUR
6/24/202611.70 EUR
6/23/202611.70 EUR
6/22/202611.70 EUR
6/19/202611.70 EUR
6/18/202611.80 EUR
6/17/202612.00 EUR
6/16/202611.90 EUR
6/15/202611.80 EUR
6/12/202612.40 EUR
6/11/202612.50 EUR
6/10/202612.70 EUR
6/9/202612.70 EUR
6/8/202612.80 EUR
6/5/202612.70 EUR
6/4/202612.80 EUR
6/3/202612.90 EUR
6/2/202613.30 EUR
6/1/202613.20 EUR
5/29/202613.00 EUR
5/28/202613.60 EUR
5/27/202613.20 EUR
5/26/202613.40 EUR
5/25/202613.40 EUR
5/22/202613.20 EUR
5/21/202613.70 EUR
5/20/202615.30 EUR
5/19/202615.30 EUR
5/18/202615.10 EUR
5/15/202615.00 EUR
5/14/202614.90 EUR
5/13/202615.10 EUR
5/12/202615.20 EUR
5/11/202615.20 EUR
5/8/202615.40 EUR
5/7/202615.40 EUR
5/6/202614.80 EUR
5/5/202614.80 EUR
5/4/202614.70 EUR
4/30/202613.60 EUR
4/29/202613.20 EUR
4/28/202613.00 EUR
4/27/202612.50 EUR
4/24/202612.60 EUR
4/23/202612.50 EUR
4/22/202612.40 EUR
4/21/202612.40 EUR
4/20/202612.40 EUR
4/17/202612.60 EUR
4/16/202612.60 EUR
4/15/202612.60 EUR
4/14/202612.50 EUR
4/13/202612.50 EUR
4/10/202612.30 EUR
4/9/202611.50 EUR
4/8/202610.80 EUR
4/7/202610.90 EUR
4/2/202611.00 EUR
3/27/202611.40 EUR
3/26/202611.20 EUR
3/25/202611.60 EUR
3/24/202611.60 EUR
3/23/202611.30 EUR
3/20/202611.90 EUR
3/19/202612.20 EUR
3/18/202612.20 EUR
3/17/202612.20 EUR
3/16/202612.00 EUR
3/13/202612.00 EUR
3/12/202612.10 EUR
3/10/202612.10 EUR
3/9/202612.10 EUR
3/6/202612.40 EUR
3/3/202612.60 EUR
2/25/202612.90 EUR
2/24/202612.90 EUR
2/20/202613.00 EUR
2/19/202612.80 EUR
2/18/202613.00 EUR
2/17/202612.40 EUR
2/16/202613.50 EUR
2/13/202613.40 EUR
2/12/202613.60 EUR
2/11/202613.60 EUR
2/10/202613.40 EUR
2/9/202613.40 EUR
2/6/202612.80 EUR
2/5/202612.80 EUR
2/4/202612.80 EUR
2/3/202613.10 EUR
2/2/202613.30 EUR
1/30/202613.10 EUR
1/29/202613.30 EUR
1/28/202613.30 EUR
1/27/202613.30 EUR
1/26/202613.00 EUR
1/23/202613.30 EUR
1/22/202612.90 EUR
1/21/202612.70 EUR
1/20/202612.70 EUR
1/19/202612.90 EUR
1/16/202613.00 EUR
1/15/202613.00 EUR
1/14/202612.90 EUR
1/13/202612.90 EUR
1/12/202613.00 EUR
1/9/202612.80 EUR
1/8/202612.80 EUR
1/7/202612.70 EUR
1/6/202613.20 EUR
1/5/202612.80 EUR
1/2/202612.60 EUR
12/30/202512.40 EUR
12/29/202511.90 EUR
12/23/202511.30 EUR
12/22/202511.30 EUR
12/19/202511.10 EUR
12/18/202511.10 EUR
12/17/202511.10 EUR
12/16/202511.00 EUR
12/15/202511.20 EUR
12/12/202511.30 EUR
12/11/202511.40 EUR
12/10/202511.60 EUR
12/9/202511.70 EUR
12/8/202511.60 EUR
12/5/202511.50 EUR
12/4/202511.70 EUR
12/3/202511.80 EUR
12/2/202511.80 EUR
12/1/202511.40 EUR
11/28/202511.40 EUR
11/27/202511.50 EUR
11/26/202511.70 EUR
11/25/202511.70 EUR
11/24/202511.80 EUR
11/21/202511.00 EUR
11/20/202511.10 EUR
11/19/202511.50 EUR
11/18/202512.00 EUR
11/17/202511.80 EUR
11/14/202511.50 EUR
11/13/202511.80 EUR
11/12/202512.10 EUR
11/11/202512.10 EUR
11/10/202512.30 EUR
11/7/202512.20 EUR
11/6/202512.20 EUR
11/5/202512.20 EUR
11/4/202512.10 EUR
11/3/202512.20 EUR
10/31/202512.40 EUR
10/30/202512.40 EUR
10/29/202512.20 EUR
10/28/202512.30 EUR
10/27/202512.30 EUR
10/24/202512.50 EUR
10/23/202512.80 EUR
10/22/202512.70 EUR
10/21/202513.00 EUR
10/20/202513.10 EUR
10/17/202513.00 EUR
10/16/202513.10 EUR
10/15/202513.10 EUR
10/14/202513.20 EUR
10/13/202513.30 EUR
10/10/202513.20 EUR
10/9/202513.40 EUR
10/8/202513.30 EUR
10/7/202513.50 EUR
10/6/202513.10 EUR
10/3/202513.10 EUR
10/2/202513.00 EUR
10/1/202512.90 EUR
9/30/202513.00 EUR
9/29/202512.90 EUR
9/26/202512.80 EUR
9/25/202512.90 EUR
9/24/202512.90 EUR
9/23/202513.00 EUR
9/22/202512.90 EUR
9/19/202512.90 EUR
9/18/202512.80 EUR
9/17/202512.80 EUR
9/16/202512.90 EUR
9/15/202512.90 EUR
9/12/202513.20 EUR
9/11/202513.00 EUR
9/10/202512.80 EUR
9/9/202512.90 EUR
9/8/202512.50 EUR
9/5/202512.10 EUR
9/4/202512.10 EUR
9/3/202512.20 EUR
9/2/202512.50 EUR
9/1/202512.40 EUR
8/29/202512.10 EUR
8/28/202512.10 EUR
8/27/202511.90 EUR
8/26/202511.80 EUR
8/25/202511.60 EUR
8/22/202511.80 EUR
8/21/202511.60 EUR
8/20/202512.00 EUR
8/19/202511.80 EUR
8/18/202511.60 EUR
8/15/202511.70 EUR
8/14/202511.80 EUR
8/13/202512.00 EUR
8/12/202511.90 EUR
8/11/202511.80 EUR
8/8/202511.90 EUR
8/7/202512.00 EUR
8/6/202512.00 EUR
8/5/202512.10 EUR
8/4/202512.10 EUR
8/1/202512.10 EUR
7/31/202512.10 EUR
7/30/202512.10 EUR
7/29/202512.20 EUR
7/28/202512.40 EUR
7/25/202512.60 EUR
7/24/202512.80 EUR
Access this data via the Eulerpool API
Get Free API Key

DocCheck Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
28.34 M EUR
3.80 M EUR
2.27 M EUR
Jan 1, 2019
32.32 M EUR
4.58 M EUR
3.14 M EUR
Jan 1, 2020
63.10 M EUR
13.47 M EUR
9.20 M EUR
Jan 1, 2021
85.92 M EUR
16.66 M EUR
11.40 M EUR
Jan 1, 2022
60.90 M EUR
10.53 M EUR
6.29 M EUR
Jan 1, 2023
53.41 M EUR
3.54 M EUR
2.27 M EUR
Jan 1, 2024
53.79 M EUR
6.47 M EUR
5.28 M EUR
Jan 1, 2025
55.32 M EUR
7.61 M EUR
5.33 M EUR

DocCheck Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 24, 2026, 5:16 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
DIV.EUR
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
15.0017.0018.0017.0019.0026.0025.0028.0028.0032.0063.0085.0060.0053.0053.0055.00
-6.2513.335.88-5.5611.7636.84-3.8512.00–14.2996.8834.92-29.41-11.67–3.77
60.0058.8222.2223.5326.3226.9228.0028.5728.5725.0028.5724.7123.3322.6418.8721.82
9.0010.004.004.005.007.007.008.008.008.0018.0021.0014.0012.0010.0012.00
–1.001.001.002.003.004.003.003.004.0013.0016.0010.003.006.007.00
–5.885.565.8810.5311.5416.0010.7110.7112.5020.6318.8216.675.6611.3212.73
–1.001.001.001.002.002.002.002.003.009.0011.006.002.005.005.00
–––––100.00–––50.00200.0022.22-45.45-66.67150.00–
––0.250.200.200.350.400.400.400.400.101.001.000.750.500.75
–––-20.00–75.0014.29–––-75.00900.00–-25.00-33.3350.00
5.285.284.994.994.995.005.015.035.024.995.055.075.065.075.075.07
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales DocCheck generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue DocCheck retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare DocCheck's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares DocCheck has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against DocCheck's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

DocCheck stock margins

The DocCheck margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocCheck. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocCheck.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
29.35 %
13.39 %
8.03 %
Jan 1, 2019
25.76 %
14.16 %
9.71 %
Jan 1, 2020
28.94 %
21.34 %
14.58 %
Jan 1, 2021
25.07 %
19.39 %
13.27 %
Jan 1, 2022
23.12 %
17.30 %
10.33 %
Jan 1, 2023
24.29 %
6.63 %
4.25 %
Jan 1, 2024
19.58 %
12.02 %
9.82 %
Jan 1, 2025
22.20 %
13.75 %
9.64 %

DocCheck Stock Revenue, EBIT, Earnings per Share

The DocCheck earnings per share therefore indicates how much revenue DocCheck has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
5.65 EUR
0.76 EUR
0.45 EUR
Jan 1, 2019
6.48 EUR
0.92 EUR
0.63 EUR
Jan 1, 2020
12.49 EUR
2.67 EUR
1.82 EUR
Jan 1, 2021
16.96 EUR
3.29 EUR
2.25 EUR
Jan 1, 2022
12.04 EUR
2.08 EUR
1.24 EUR
Jan 1, 2023
10.53 EUR
0.70 EUR
0.45 EUR
Jan 1, 2024
10.60 EUR
1.27 EUR
1.04 EUR
Jan 1, 2025
10.90 EUR
1.50 EUR
1.05 EUR

DocCheck business model & stock analysis

DocCheck AG is a German company that was established in Cologne in 1996. It is the largest European specialist portal for medical professionals and provides various products and services for doctors, pharmacists, and pharmaceutical professionals. Initially, the company focused primarily on offering continuing education for doctors and job placement in the medical field. However, soon the business model expanded and additional sectors were added. An important pillar of the company is the online portal DocCheck.com. Here, medical professionals can register and gain access to exclusive content including specialized articles, studies, and videos, as well as receive updates and news from the medical field. Additionally, the company offers a wide range of medical workwear and accessories. The products range from disposable gloves to stethoscopes and medical torches. The assortment is regularly updated and expanded. Another important area of focus is job placement in the medical sector. DocCheck is one of the largest providers on the German market for medical job advertisements. Employers can place ads for a fee, and job seekers can find suitable job offers. A special highlight for customers is the so-called DocCheck Flexikon. It is an online lexicon for medical terms, continuously revised and updated by specialists. The Flexikon is also available as a smartphone and tablet app. Overall, DocCheck is a company with a wide range of products and services tailored to the needs of medical professionals. In recent years, the company has become an important partner in the healthcare sector in Germany and Europe, and it has become an essential player in the industry.

DocCheck SWOT Analysis

Strengths

  • DocCheck AG has a strong brand reputation and recognition in the healthcare industry.
  • The company offers a comprehensive range of digital solutions and services tailored for healthcare professionals and organizations.
  • DocCheck AG has established a large and loyal customer base, which contributes to stable revenue streams.

Weaknesses

  • The company heavily relies on its digital platform, which makes it vulnerable to potential technological disruptions or cybersecurity threats.
  • DocCheck AG faces competition from other established players in the healthcare technology sector, which may limit its market share.
  • The company's growth is dependent on expanding its customer base and acquiring new markets, which can be challenging in highly regulated healthcare environments.

Opportunities

  • The increasing adoption of digital solutions in the healthcare industry presents an opportunity for DocCheck AG to expand its services and reach a broader market.
  • The company can leverage data analytics and artificial intelligence to develop innovative solutions that improve patient care and operational efficiency.
  • International expansion into new markets with less competition can help DocCheck AG accelerate growth and diversify its revenue streams.

Threats

  • Changing regulatory policies and compliance requirements in the healthcare industry can pose challenges for DocCheck AG's operations and product development.
  • The emergence of new competitors or disruptive technologies may impact the company's market position and profitability.
  • Economic downturns or financial instability could lead to reduced healthcare spending, which could affect the demand for DocCheck AG's services.

DocCheck Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

DocCheck historical P/E ratio, EBIT multiple, and P/S ratio

DocCheck annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

DocCheck shares outstanding

The number of shares of DocCheck was 5.07 M in 2025. This indicates how many shares DocCheck is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
5.02 M Stocks
Jan 1, 2019
4.99 M Stocks
Jan 1, 2020
5.05 M Stocks
Jan 1, 2021
5.07 M Stocks
Jan 1, 2022
5.06 M Stocks
Jan 1, 2023
5.07 M Stocks
Jan 1, 2024
5.07 M Stocks
Jan 1, 2025
5.07 M Stocks

DocCheck Dividend History

14 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.75EUR↑ 50.0%1×
May 29, 20250.75EUR↑ 50.0%1/1
20240.50EUR↓ 33.3%1×
20230.75EUR↓ 25.0%1×
20221.00EUR 0.0%1×
20211.00EUR↑ 900.0%1×
20200.10EUR↓ 75.0%1×
20190.40EUR 0.0%1×
20180.40EUR 0.0%1×
20170.40EUR 0.0%1×
20160.40EUR↑ 14.3%1×

DocCheck dividend history and estimates

In 2025, DocCheck paid a dividend amounting to 0.75 EUR. Dividend means that DocCheck distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.40 EUR
0.00 EUR
Jan 1, 2019
0.40 EUR
0.00 EUR
Jan 1, 2020
0.10 EUR
0.00 EUR
Jan 1, 2021
1.00 EUR
0.00 EUR
Jan 1, 2022
1.00 EUR
0.00 EUR
Jan 1, 2023
0.75 EUR
0.00 EUR
Jan 1, 2024
0.50 EUR
0.00 EUR
Jan 1, 2025
0.75 EUR
0.00 EUR

DocCheck dividend payout ratio

In 2025, DocCheck had a payout ratio of 71.34%. The payout ratio indicates the percentage of the company's profits that DocCheck distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
88.23 %
Jan 1, 2019
63.57 %
Jan 1, 2020
5.49 %
Jan 1, 2021
44.43 %
Jan 1, 2022
80.43 %
Jan 1, 2023
167.53 %
Jan 1, 2024
48.02 %
Jan 1, 2025
71.34 %
Price targets and forecasts for DocCheck are not yet available.

DocCheck shareholder structure

% Name
55.83017%
Antwerpes (Frank)
Antwerpes (Frank)
16.09005%
Antwerpes (Pia)
Antwerpes (Pia)
7.76002%
Investmentaktiengesellschaft für Langfristige Investoren TGV
Investmentaktiengesellschaft für Langfristige Investoren TGV
0.78836%
Principal Vermögensverwaltung AG
Principal Vermögensverwaltung AG
0.15767%
Signal Iduna Asset Management GmbH
Signal Iduna Asset Management GmbH
0.15767%
HANSAINVEST Hanseatische Investment GmbH
HANSAINVEST Hanseatische Investment GmbH

DocCheck Executives and Management Board

FA

Dr. Frank Antwerpes

Chief Executive Officer · since 2023

Compensation249,996.00 EUR
TK

Mr. Thilo Koelzer

Chief Operating Officer, Member of the Management Board

Compensation244,582.00 EUR
PS

Mr. Philip Stadtmann

Chief Financial Officer, Member of the Management Board

Compensation206,606.00 EUR
JK

Mr. Jens Knoop

Chief Technology Officer, Member of the Management Board

Compensation184,471.00 EUR
JP

Dr. Joachim Pietzko

Chairman of the Supervisory Board

Compensation34,800.00 EUR

Frequently asked questions about DocCheck

The business model of DocCheck AG revolves around providing an online platform and services for healthcare professionals. DocCheck offers a range of products such as DocCheck Login, which enables secure access to medical content, and the Medicus app that allows doctors to access medical information on their mobile devices. Additionally, the company offers DocCheck Shop, an e-commerce platform for medical supplies and equipment. DocCheck AG aims to connect healthcare professionals, facilitate information exchange, and provide convenient solutions for the medical community. Its platform and services play a crucial role in supporting healthcare professionals in their daily work and improving patient care.

All fundamentals and in-depth analysis of DocCheck

Our stock analysis for DocCheck stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocCheck. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

DocCheck Stock
DocCheck Revenue→
DocCheck Stock
DocCheck Net Income→
DocCheck Stock
DocCheck P/E→
DocCheck Stock
DocCheck P/S→
DocCheck Stock
DocCheck EBIT→
DocCheck Stock
DocCheck Dividend→
DocCheck Stock
DocCheck Directors Dealings→
DocCheck Stock
DocCheck Stocks→
DocCheck Stock
DocCheck Market capitalization→
DocCheck Stock
DocCheck Debt→
DocCheck Stock
DocCheck Liabilities→
DocCheck Stock
DocCheck Equity→
DocCheck Stock
DocCheck AAQS→
DocCheck Stock
DocCheck Employees→
DocCheck Stock
DocCheck ROE→
DocCheck Stock
DocCheck ROA→
DocCheck Stock
DocCheck ROCE→
DocCheck Stock
DocCheck News→
DocCheck Stock
DocCheck Analyst Price Targets→

Health Stocks

DocGoDNAPrint GenomicsDocMode Health TechnologiesDizal Pharmaceutical CoDoctorglasses Chain CoDivi's LaboratoriesDogwood TherapeuticsDishman Carbogen AmcisDomesco Medical Import Export Joint StockDisc MedicineDominari HoldingsDirui Industrial CoAll Stocks A–Z →